Popular Articles
Cellulite Cream

NYU Langone Medical Center Awarded NIH Grants Totaling $1,560,000
Two NYU Langone Medical Center researchers have received $1,560,000 in grant support for their first year of studies focused on microbiome and psoriasis and on microbiome and esophageal cancer from the National Institutes of Health (NIH). The studies being conducted at NYU Langone Medical Center are two of several projects being conducted through the NIH Roadmap for Medical Research as part of the Human Microbiome Project (HMP) taking place at institutions across the country.
generic viagra online
New Scientific Data On ADHD Treatments Presented By Shire At National Psychiatric Scientific Meeting
Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, has announced that it will present key scientific data on its Attention Deficit Hyperactivity Disorder (ADHD) treatments lisdexamfetamine dimesylate (CII) and investigational non-scheduled guanfacine extended release, at a national scientific meeting of psychiatrists being held May 16 -21 in San Francisco, CA.
News of the day
TAU Develops Tiny Device To "Sniff Out" Disease, Heart Attacks, Poison And Environmental Pollution
Like the sensitive seismographs that can pick up tremors of impending earthquakes long before they strike, a similar invention from Tel Aviv University researchers may change the face of molecular biology.
Oncology

New Research Into Treatment Availability For People With Obsessive-Compulsive Disorder, UK

OCD-UK, the leading national charity for people with Obsessive-Compulsive Disorder with the support of a grant from Comic Relief has announced a year long research project to understand and evaluate if treatment guidelines have had a positive impact on providing treatment for people with OCD across the UK. In 2005 the National Institute for Health and Clinical Excellence (NICE) launched a set of guidelines for the identification, treatment and management of Obsessive Compulsive Disorder (OCD). In general, healthcare professionals in the NHS are expected to follow NICE"s clinical guidelines for the treatment of the illness. OCD-UK Chief-Executive Ashley Fulwood commented. "Since 2005 these guidelines have been freely available to Primary Care and Mental Health Trusts, yet despite this we are receiving complaints on a daily basis from individuals claiming that they still can not access the correct form of therapy". "This research will provide us with the hard evidence about which Trusts are adhering to the treatment recommendations from NICE, and which have still yet to implement them some 4 years later. People with OCD deserve access to the correct form of treatment today, not tomorrow." OCD-UK intends to measure services now, and use the data collated to ensure the government"s current initiative to Improve Access to Psychological Therapies (IAPT) has a significant benefit to the OCD community as it is fully rolled out over the next 3 years. Results of this research will be shared with National Institute for Health and Clinical Excellence and the Care Quality Commission (formerly Healthcare Commission). For more information about Obsessive-Compulsive Disorder people visit the OCD-UK website at http://www.ocduk.org It is our belief that everyone affected by Obsessive Compulsive Disorder should receive the most appropriate and the highest quality standards of care, support and treatment. Our objective is to make a positive and meaningful difference in the everyday lives of people affected by Obsessive Compulsive Disorder, by providing accessible and effective support services and by campaigning for improved access and quality treatment and care for people with OCD. We believe it is vital that every person affected by OCD receives the highest quality of treatment and care that they are entitled to and deserve. OCD-UK


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):